Cargando…
重组人血管内皮抑制素静脉持续泵入联合窗口期动脉灌注化疗治疗晚期肺鳞癌的临床观察
BACKGROUND AND OBJECTIVE: Lung cancer is one of the most common malignant tumors in China. The aim of this study is to observe the efficacy and safety of recombinant human vascular endostatin (endostar) durative transfusion combined with window period arterial infusion chemotherapy in the treatment...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000236/ https://www.ncbi.nlm.nih.gov/pubmed/26302347 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.08.05 |
Ejemplares similares
-
重组人血管内皮抑制素在晚期肺鳞癌治疗中的临床应用
Publicado: (2016) -
重组人血管内皮抑制素联合放射治疗对lewis肺癌小鼠的作用
Publicado: (2010) -
重组人血管内皮抑素与多西紫杉醇不同顺序用药调控移植瘤组织MMP及抗瘤效应观察
Publicado: (2010) -
胸腔内注射重组人血管内皮抑素对裸鼠恶性胸腔积液的治疗作用
Publicado: (2015) -
重组人血管内皮抑制素联合贝伐珠单抗体内抑瘤作用的效果及分析
Publicado: (2013)